Injection moulded controlled release amorphous solid dispersions: Synchronized drug and polymer release for robust performance

Abstract

A study has been carried out to investigate controlled release performance of caplet shaped injection moulded (IM) amorphous solid dispersion (ASD) tablets based on the model drug AZD0837 and polyethylene oxide (PEO). The physical/chemical storage stability and release robustness of the IM tablets were characterized and compared to that of conventional extended release (ER) hydrophilic matrix tablets of the same raw materials and compositions manufactured via direct compression (DC). To gain an improved understanding of the release mechanisms, the dissolution of both the polymer and the drug were studied. Under conditions where the amount of dissolution media was limited, the controlled release ASD IM tablets demonstrated complete and synchronized release of both PEO and AZD0837 whereas the release of AZD0837 was found to be slower and incomplete from conventional direct compressed ER hydrophilic matrix tablets. The results clearly indicated that AZD0837 remained amorphous throughout the dissolution process and was maintained in a supersaturated state and hence kept stable with the aid of the polymeric carrier when released in a synchronized manner. In addition, it was found that the IM tablets were robust to variation in hydrodynamics of the dissolution environment and PEO molecular weight.

Investigating in-vitro functionality and in-vivo taste assessment of eco-friendly Tadalafil Pastilles

“…Polyox N 10 is a water-soluble resin of a long polyethylene oxide chain with a high molecular weight. Due to its resinous and film-forming nature, it slightly reduces the drug release but helps maintain the pastilles' structural integrity [ 94 ]. PEG has several hydroxyl groups in the structure, so it modifies the drug release profile [ 53 ].…”

PEO hot melt extrudates for controlled drug delivery: Importance of the type of drug and loading

“…A variety of PEO grades, differing in polymer molecular weight are commercially available. Drug loaded PEO matrices can be prepared by several processes, such as compression [6,7,8], injection molding [9,10], 3D printing [11] or hot melt extrusion [12,13,14].…”

High-Drug-Loading Amorphous Solid Dispersions via In Situ Thermal Cross-Linking: Unraveling the Mechanisms of Stabilization

“…Amorphous solid dispersions (ASDs) have attracted the interest of several pharmaceutical formulation scientists due to their unique features and a wide variety of applications. By definition, such systems consist of an amorphous active pharmaceutical ingredient (API) stabilized by an excipient (or mixture of excipients) that acts as a matrix/carrier improving its physical stability and in vivo characteristics. , In these drug delivery formulations, the proper selection of the matrix/carriers transfuses many advantageous properties into the system (such as the reduction of API’s particle size up to the molecular level, enhancement or suppression of wettability and porosity, etc. , ) that, if controlled properly, may result in a wide variety of pharmaceutical products, such as immediate- or controlled-release per os formulations, − buccal mucoadhesive or skin patches, , long-acting injectables, etc.…”